Drug profile · INN
gallium citrate ga-67
NEOSCAN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
gallium citrate ga-67 (NEOSCAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN gallium citrate ga-67
Brand NEOSCAN
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is gallium citrate ga-67?
gallium citrate ga-67 (NEOSCAN) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gallium citrate ga-67?
NEOSCAN is a marketed brand name for gallium citrate ga-67. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gallium citrate ga-67?
gallium citrate ga-67 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.